0.00Open0.00Pre Close0 Volume0 Open Interest915.00Strike Price0.00Turnover5382.83%IV-18.88%PremiumJan 3, 2025Expiry Date145.31Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9821Delta0.0008Gamma--Leverage Ratio-1692.0566Theta0.0000Rho0.00Eff Leverage0.0005Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet